1 Study Coverage
    1.1 Oral Hypoglycemic Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Oral Hypoglycemic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Sulfonylureas (SU)
        1.2.3 Double Guanidine
        1.2.4 Glucosidase Inhibitor
        1.2.5 Insulin Synergist
    1.3 Market by Application
        1.3.1 Global Oral Hypoglycemic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Oral Hypoglycemic Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Oral Hypoglycemic Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Oral Hypoglycemic Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Oral Hypoglycemic Drugs Sales by Region
        2.4.1 Global Oral Hypoglycemic Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Oral Hypoglycemic Drugs by Region (2023-2028)
    2.5 Global Oral Hypoglycemic Drugs Revenue by Region
        2.5.1 Global Oral Hypoglycemic Drugs Revenue by Region (2017-2022)
        2.5.2 Global Oral Hypoglycemic Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Oral Hypoglycemic Drugs Sales by Manufacturers
        3.1.1 Global Top Oral Hypoglycemic Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Oral Hypoglycemic Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Hypoglycemic Drugs in 2021
    3.2 Global Oral Hypoglycemic Drugs Revenue by Manufacturers
        3.2.1 Global Oral Hypoglycemic Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Oral Hypoglycemic Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Oral Hypoglycemic Drugs Revenue in 2021
    3.3 Global Oral Hypoglycemic Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Oral Hypoglycemic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Oral Hypoglycemic Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Oral Hypoglycemic Drugs Sales by Type
        4.1.1 Global Oral Hypoglycemic Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Oral Hypoglycemic Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Oral Hypoglycemic Drugs Revenue by Type
        4.2.1 Global Oral Hypoglycemic Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Oral Hypoglycemic Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Oral Hypoglycemic Drugs Price by Type
        4.3.1 Global Oral Hypoglycemic Drugs Price by Type (2017-2022)
        4.3.2 Global Oral Hypoglycemic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Oral Hypoglycemic Drugs Sales by Application
        5.1.1 Global Oral Hypoglycemic Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Oral Hypoglycemic Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Oral Hypoglycemic Drugs Revenue by Application
        5.2.1 Global Oral Hypoglycemic Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Oral Hypoglycemic Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Oral Hypoglycemic Drugs Price by Application
        5.3.1 Global Oral Hypoglycemic Drugs Price by Application (2017-2022)
        5.3.2 Global Oral Hypoglycemic Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Oral Hypoglycemic Drugs Market Size by Type
        6.1.1 North America Oral Hypoglycemic Drugs Sales by Type (2017-2028)
        6.1.2 North America Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
    6.2 North America Oral Hypoglycemic Drugs Market Size by Application
        6.2.1 North America Oral Hypoglycemic Drugs Sales by Application (2017-2028)
        6.2.2 North America Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
    6.3 North America Oral Hypoglycemic Drugs Market Size by Country
        6.3.1 North America Oral Hypoglycemic Drugs Sales by Country (2017-2028)
        6.3.2 North America Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Oral Hypoglycemic Drugs Market Size by Type
        7.1.1 Europe Oral Hypoglycemic Drugs Sales by Type (2017-2028)
        7.1.2 Europe Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
    7.2 Europe Oral Hypoglycemic Drugs Market Size by Application
        7.2.1 Europe Oral Hypoglycemic Drugs Sales by Application (2017-2028)
        7.2.2 Europe Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
    7.3 Europe Oral Hypoglycemic Drugs Market Size by Country
        7.3.1 Europe Oral Hypoglycemic Drugs Sales by Country (2017-2028)
        7.3.2 Europe Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Oral Hypoglycemic Drugs Market Size by Type
        8.1.1 Asia Pacific Oral Hypoglycemic Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Oral Hypoglycemic Drugs Market Size by Application
        8.2.1 Asia Pacific Oral Hypoglycemic Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Oral Hypoglycemic Drugs Market Size by Region
        8.3.1 Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Oral Hypoglycemic Drugs Market Size by Type
        9.1.1 Latin America Oral Hypoglycemic Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
    9.2 Latin America Oral Hypoglycemic Drugs Market Size by Application
        9.2.1 Latin America Oral Hypoglycemic Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
    9.3 Latin America Oral Hypoglycemic Drugs Market Size by Country
        9.3.1 Latin America Oral Hypoglycemic Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Oral Hypoglycemic Drugs Market Size by Type
        10.1.1 Middle East and Africa Oral Hypoglycemic Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Oral Hypoglycemic Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Oral Hypoglycemic Drugs Market Size by Application
        10.2.1 Middle East and Africa Oral Hypoglycemic Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Oral Hypoglycemic Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Oral Hypoglycemic Drugs Market Size by Country
        10.3.1 Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Recent Developments
    11.2 AstraZeneca
        11.2.1 AstraZeneca Corporation Information
        11.2.2 AstraZeneca Overview
        11.2.3 AstraZeneca Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AstraZeneca Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AstraZeneca Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Corporation Information
        11.3.2 Johnson & Johnson Overview
        11.3.3 Johnson & Johnson Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Johnson & Johnson Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Johnson & Johnson Recent Developments
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Corporation Information
        11.4.2 GlaxoSmithKline Overview
        11.4.3 GlaxoSmithKline Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 GlaxoSmithKline Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 GlaxoSmithKline Recent Developments
    11.5 Merck & Co
        11.5.1 Merck & Co Corporation Information
        11.5.2 Merck & Co Overview
        11.5.3 Merck & Co Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Merck & Co Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Merck & Co Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Corporation Information
        11.6.2 Eli Lilly Overview
        11.6.3 Eli Lilly Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Eli Lilly Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Eli Lilly Recent Developments
    11.7 Sanofi
        11.7.1 Sanofi Corporation Information
        11.7.2 Sanofi Overview
        11.7.3 Sanofi Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Sanofi Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Sanofi Recent Developments
    11.8 Takeda Pharmaceuticals
        11.8.1 Takeda Pharmaceuticals Corporation Information
        11.8.2 Takeda Pharmaceuticals Overview
        11.8.3 Takeda Pharmaceuticals Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Takeda Pharmaceuticals Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Takeda Pharmaceuticals Recent Developments
    11.9 Novo Nordisk
        11.9.1 Novo Nordisk Corporation Information
        11.9.2 Novo Nordisk Overview
        11.9.3 Novo Nordisk Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Novo Nordisk Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Novo Nordisk Recent Developments
    11.10 Servier Laboratories
        11.10.1 Servier Laboratories Corporation Information
        11.10.2 Servier Laboratories Overview
        11.10.3 Servier Laboratories Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Servier Laboratories Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Servier Laboratories Recent Developments
    11.11 Boehringer Ingelheim
        11.11.1 Boehringer Ingelheim Corporation Information
        11.11.2 Boehringer Ingelheim Overview
        11.11.3 Boehringer Ingelheim Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Boehringer Ingelheim Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Boehringer Ingelheim Recent Developments
    11.12 Bristol-Myers Squibb
        11.12.1 Bristol-Myers Squibb Corporation Information
        11.12.2 Bristol-Myers Squibb Overview
        11.12.3 Bristol-Myers Squibb Oral Hypoglycemic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Bristol-Myers Squibb Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Bristol-Myers Squibb Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Oral Hypoglycemic Drugs Industry Chain Analysis
    12.2 Oral Hypoglycemic Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oral Hypoglycemic Drugs Production Mode & Process
    12.4 Oral Hypoglycemic Drugs Sales and Marketing
        12.4.1 Oral Hypoglycemic Drugs Sales Channels
        12.4.2 Oral Hypoglycemic Drugs Distributors
    12.5 Oral Hypoglycemic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Oral Hypoglycemic Drugs Industry Trends
    13.2 Oral Hypoglycemic Drugs Market Drivers
    13.3 Oral Hypoglycemic Drugs Market Challenges
    13.4 Oral Hypoglycemic Drugs Market Restraints
14 Key Findings in The Global Oral Hypoglycemic Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Oral Hypoglycemic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Sulfonylureas (SU)
    Table 3. Major Manufacturers of Double Guanidine
    Table 4. Major Manufacturers of Glucosidase Inhibitor
    Table 5. Major Manufacturers of Insulin Synergist
    Table 6. Global Oral Hypoglycemic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Oral Hypoglycemic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Oral Hypoglycemic Drugs Sales by Region (2017-2022) & (K Units)
    Table 9. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2017-2022)
    Table 10. Global Oral Hypoglycemic Drugs Sales by Region (2023-2028) & (K Units)
    Table 11. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2023-2028)
    Table 12. Global Oral Hypoglycemic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Oral Hypoglycemic Drugs Revenue Market Share by Region (2017-2022)
    Table 14. Global Oral Hypoglycemic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Oral Hypoglycemic Drugs Revenue Market Share by Region (2023-2028)
    Table 16. Global Oral Hypoglycemic Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Oral Hypoglycemic Drugs Sales Share by Manufacturers (2017-2022)
    Table 18. Global Oral Hypoglycemic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Oral Hypoglycemic Drugs Revenue Share by Manufacturers (2017-2022)
    Table 20. Oral Hypoglycemic Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 21. Global Oral Hypoglycemic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Oral Hypoglycemic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Hypoglycemic Drugs as of 2021)
    Table 23. Oral Hypoglycemic Drugs Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Oral Hypoglycemic Drugs Product Offered
    Table 25. Date of Manufacturers Enter into Oral Hypoglycemic Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
    Table 28. Global Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
    Table 29. Global Oral Hypoglycemic Drugs Sales Share by Type (2017-2022)
    Table 30. Global Oral Hypoglycemic Drugs Sales Share by Type (2023-2028)
    Table 31. Global Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Oral Hypoglycemic Drugs Revenue Share by Type (2017-2022)
    Table 34. Global Oral Hypoglycemic Drugs Revenue Share by Type (2023-2028)
    Table 35. Oral Hypoglycemic Drugs Price by Type (2017-2022) & (US$/Unit)
    Table 36. Global Oral Hypoglycemic Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 37. Global Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
    Table 38. Global Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
    Table 39. Global Oral Hypoglycemic Drugs Sales Share by Application (2017-2022)
    Table 40. Global Oral Hypoglycemic Drugs Sales Share by Application (2023-2028)
    Table 41. Global Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Oral Hypoglycemic Drugs Revenue Share by Application (2017-2022)
    Table 44. Global Oral Hypoglycemic Drugs Revenue Share by Application (2023-2028)
    Table 45. Oral Hypoglycemic Drugs Price by Application (2017-2022) & (US$/Unit)
    Table 46. Global Oral Hypoglycemic Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 47. North America Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
    Table 48. North America Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
    Table 49. North America Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
    Table 52. North America Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
    Table 53. North America Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
    Table 56. North America Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
    Table 57. North America Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Oral Hypoglycemic Drugs Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Oral Hypoglycemic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Oral Hypoglycemic Drugs Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Oral Hypoglycemic Drugs Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Oral Hypoglycemic Drugs Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Oral Hypoglycemic Drugs Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Oral Hypoglycemic Drugs Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Oral Hypoglycemic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Pfizer Corporation Information
    Table 108. Pfizer Description and Major Businesses
    Table 109. Pfizer Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Pfizer Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Pfizer Recent Developments
    Table 112. AstraZeneca Corporation Information
    Table 113. AstraZeneca Description and Major Businesses
    Table 114. AstraZeneca Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. AstraZeneca Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. AstraZeneca Recent Developments
    Table 117. Johnson & Johnson Corporation Information
    Table 118. Johnson & Johnson Description and Major Businesses
    Table 119. Johnson & Johnson Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. Johnson & Johnson Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Johnson & Johnson Recent Developments
    Table 122. GlaxoSmithKline Corporation Information
    Table 123. GlaxoSmithKline Description and Major Businesses
    Table 124. GlaxoSmithKline Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. GlaxoSmithKline Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. GlaxoSmithKline Recent Developments
    Table 127. Merck & Co Corporation Information
    Table 128. Merck & Co Description and Major Businesses
    Table 129. Merck & Co Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. Merck & Co Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Merck & Co Recent Developments
    Table 132. Eli Lilly Corporation Information
    Table 133. Eli Lilly Description and Major Businesses
    Table 134. Eli Lilly Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 135. Eli Lilly Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Eli Lilly Recent Developments
    Table 137. Sanofi Corporation Information
    Table 138. Sanofi Description and Major Businesses
    Table 139. Sanofi Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 140. Sanofi Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Sanofi Recent Developments
    Table 142. Takeda Pharmaceuticals Corporation Information
    Table 143. Takeda Pharmaceuticals Description and Major Businesses
    Table 144. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 145. Takeda Pharmaceuticals Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Takeda Pharmaceuticals Recent Developments
    Table 147. Novo Nordisk Corporation Information
    Table 148. Novo Nordisk Description and Major Businesses
    Table 149. Novo Nordisk Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 150. Novo Nordisk Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Novo Nordisk Recent Developments
    Table 152. Servier Laboratories Corporation Information
    Table 153. Servier Laboratories Description and Major Businesses
    Table 154. Servier Laboratories Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 155. Servier Laboratories Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Servier Laboratories Recent Developments
    Table 157. Boehringer Ingelheim Corporation Information
    Table 158. Boehringer Ingelheim Description and Major Businesses
    Table 159. Boehringer Ingelheim Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 160. Boehringer Ingelheim Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Boehringer Ingelheim Recent Developments
    Table 162. Bristol-Myers Squibb Corporation Information
    Table 163. Bristol-Myers Squibb Description and Major Businesses
    Table 164. Bristol-Myers Squibb Oral Hypoglycemic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 165. Bristol-Myers Squibb Oral Hypoglycemic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Bristol-Myers Squibb Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Oral Hypoglycemic Drugs Distributors List
    Table 170. Oral Hypoglycemic Drugs Customers List
    Table 171. Oral Hypoglycemic Drugs Market Trends
    Table 172. Oral Hypoglycemic Drugs Market Drivers
    Table 173. Oral Hypoglycemic Drugs Market Challenges
    Table 174. Oral Hypoglycemic Drugs Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Hypoglycemic Drugs Product Picture
    Figure 3. Global Oral Hypoglycemic Drugs Market Share by Type in 2021 & 2028
    Figure 3. Sulfonylureas (SU) Product Picture
    Figure 4. Double Guanidine Product Picture
    Figure 5. Glucosidase Inhibitor Product Picture
    Figure 6. Insulin Synergist Product Picture
    Figure 7. Global Oral Hypoglycemic Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospital
    Figure 9. Clinic
    Figure 10. Others
    Figure 11. Oral Hypoglycemic Drugs Report Years Considered
    Figure 12. Global Oral Hypoglycemic Drugs Sales 2017-2028 (K Units)
    Figure 13. Global Oral Hypoglycemic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Oral Hypoglycemic Drugs Revenue 2017-2028 (US$ Million)
    Figure 15. Global Oral Hypoglycemic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2017-2022)
    Figure 17. Global Oral Hypoglycemic Drugs Sales Market Share by Region (2023-2028)
    Figure 18. North America Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Oral Hypoglycemic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Oral Hypoglycemic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Oral Hypoglycemic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Oral Hypoglycemic Drugs in the World: Market Share by Oral Hypoglycemic Drugs Revenue in 2021
    Figure 30. Global Oral Hypoglycemic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
    Figure 32. Global Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
    Figure 33. Global Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
    Figure 34. Global Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
    Figure 35. North America Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
    Figure 36. North America Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
    Figure 37. North America Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
    Figure 38. North America Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
    Figure 39. North America Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
    Figure 40. North America Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
    Figure 41. U.S. Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
    Figure 44. Europe Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
    Figure 46. Europe Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
    Figure 48. Europe Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
    Figure 49. Germany Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. France Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Oral Hypoglycemic Drugs Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Oral Hypoglycemic Drugs Revenue Share by Region (2017-2028)
    Figure 60. China Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. India Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
    Figure 75. Latin America Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
    Figure 76. Mexico Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Oral Hypoglycemic Drugs Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Oral Hypoglycemic Drugs Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Oral Hypoglycemic Drugs Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Oral Hypoglycemic Drugs Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Oral Hypoglycemic Drugs Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Oral Hypoglycemic Drugs Revenue Share by Country (2017-2028)
    Figure 85. Turkey Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Oral Hypoglycemic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Oral Hypoglycemic Drugs Value Chain
    Figure 89. Oral Hypoglycemic Drugs Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed